Randomized, Double Blind Trial of the Quadrivalent HPV Vaccine to Improve Responses to LEEP Treatment of Cervical HSIL
This study is not yet open for participant recruitment.
Verified August 2013 by University of Witwatersrand, South Africa
University of Witwatersrand, South Africa
Merck Sharp & Dohme Corp.
Information provided by (Responsible Party):
Cynthia S Firnhaber, University of Witwatersrand, South Africa
First received: August 20, 2013
Last updated: August 22, 2013
Last verified: August 2013
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study is not yet open for participant recruitment.|
|Estimated Study Completion Date:||August 2016|
|Estimated Primary Completion Date:||March 2016 (Final data collection date for primary outcome measure)|